{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011344","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.867667+00:00","generated_at":"2026-06-04T07:53:56.835005+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biotricity raises $1M in private placement of Series B Preferred Stock, with option for additional $1M","bullets":["Gross proceeds of $1M from sale of 110 Series B Convertible Preferred shares at $9,090.91 each.","Company has 30-day option to require second closing for additional $1M (110 more shares).","Series B Preferred Stock: 8% cumulative dividend (15% upon triggering event), initial conversion price $3.50, alternate conversion at 80% of lowest VWAP.","Registration rights agreement requires filing registration statement within 45 days; failure triggers issuance of 100,000 common shares.","Voting agreement with certain stockholders to support Nasdaq-required stockholder approval for conversion shares issuances."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011344","json":"https://secwatch.observer/filing/0001493152-24-011344.json","markdown":"https://secwatch.observer/filing/0001493152-24-011344.md","text":"https://secwatch.observer/filing/0001493152-24-011344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/0001493152-24-011344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:53:56.835005+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9334b31d660db180664c57c04d368aac637ba4fa","claim":"BIOTRICITY INC. entered into Purchase Agreement with an institutional investor (effective 2024-03-25).","evidence_excerpt":"On March 25, 2024, Biotricity Inc. (the “Company”) entered into a security purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the issuance and sale, in a private placement offering (the “Private Placement”), of 110 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value (the “Series B Preferred Stock”), at a purchase price of $9,090.91 per share of Series B Convertible Preferred Stock, for gross proceeds of $1,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/0001493152-24-011344-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Effective","value":"2024-03-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}